Skip to main content
NCBI home page
Canadian Journal of Public Health = Revue Canadienne de Santé Publique logoLink to Canadian Journal of Public Health = Revue Canadienne de Santé Publique
. 1999 Nov 1;90(6):392–394. [Article in French] doi: 10.1007/BF03404142

L’apport alimentaire en sodium: Le temps est venu pour une intervention de santé publique

Marie-Josée Papillon 1,✉, Alain Vanasse 1, Marie-Josée Pineault 1
PMCID: PMC6979606  PMID: 10680263

Abstract

In recent years, many studies have been published regarding the link between sodium intake and high blood pressure. Canadian, American and WHO Guidelines on the treatment of hypertension all indicate salt reduction as an efficient non-pharmacologic recommendation. However, due to the lack of clear and specific Canadian legislation on food labelling, consumers are not able to make informed choices of food products on the basis of salt content. The time has come for public health experts to join this debate.

Bibliographie

  • 1.Stamler J. Letter to the Editor. JAMA. 1996;276(18):1467. doi: 10.1001/jama.1996.03540180023012. [DOI] [Google Scholar]
  • 2.Elliot P, Stamler J, Nichols R, et al. Intersalt revisited: Further analyses of 24 hour sodium excretion and blood pressure within and across populations. BMJ. 1996;312:1249–53. doi: 10.1136/bmj.312.7041.1249. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Haddy FJ, Pamnani MB. Role of dietary salt in hypertension. J Am Coll Nutr. 1995;14(5):428–38. doi: 10.1080/07315724.1995.10718533. [DOI] [PubMed] [Google Scholar]
  • 4.Campese Vito M. Salt sensitivity in hypertension: Renal and cardiovascular implications. Hypertension. 1994;23(4):531–50. doi: 10.1161/01.HYP.23.4.531. [DOI] [PubMed] [Google Scholar]
  • 5.Chalmers J, Mancia G, Van Zwieten PA. 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. J Hypertens. 1999;17:151–83. [PubMed] [Google Scholar]
  • 6.Law MR, Frost CD, Wald NJ. By how much does dietary salt reduction lower blood pressure? I-Analysis of observational data among population. BMJ. 1991;302:811–14. doi: 10.1136/bmj.302.6780.811. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Cutler JA, Follmann D, Elliott P, Suh I. An overview of randomized trials of sodium reduction and blood pressure. Hypertension. 1991;17(supplI):I27–I33. doi: 10.1161/01.HYP.17.1_Suppl.I27. [DOI] [PubMed] [Google Scholar]
  • 8.The Trials of Hypertension Prevention Collaborative Research Group. The Effects of Nonpharmacologic Interventions on Blood Pressure of Persons With High Normal Levels: Results of the Trials of Hypertension Prevention, Phase I. JAMA. 1992;267(9):1213–20. doi: 10.1001/jama.1992.03480090061028. [DOI] [PubMed] [Google Scholar]
  • 9.Whelton PK, Appel LJ, Espeland MA. Sodium reduction and weight loss in the treatment of hypertension in older persons: A randomized controlled trial of non pharmacologic interventions in the elderly (TONE) JAMA. 1998;279(11):839–46. doi: 10.1001/jama.279.11.839. [DOI] [PubMed] [Google Scholar]
  • 10.Ramsay LE, Yeo WW, Chadwick IG, et al. Non-pharmacological therapy of hypertension. Br Med Bull. 1994;50(2):491–508. doi: 10.1093/oxfordjournals.bmb.a072905. [DOI] [PubMed] [Google Scholar]
  • 11.Midgley JP, Matthew AG, Greenwood CMT, Logan AG. Effect of reduced dietary sodium on blood pressure: A meta-analysis of randomized controlled trials. JAMA. 1996;275(20):1590–97. doi: 10.1001/jama.1996.03530440070039. [DOI] [PubMed] [Google Scholar]
  • 12.Kotchen TA. Letter To the Editor. JAMA. 1996;276(18):1467. doi: 10.1001/jama.276.18.1468b. [DOI] [Google Scholar]
  • 13.MacGregor GA, Cappuccio FP. Letter to the Editor. JAMA. 1996;276(18):1468–69. doi: 10.1001/jama.1996.03540180024015. [DOI] [PubMed] [Google Scholar]
  • 14.Alderman MA, Madhavan S, Cohen H, et al. Low urinary sodium is associated with greater risk of myocardial infarction among treated hypertensive men. Hypertension. 1995;25:1144–52. doi: 10.1161/01.HYP.25.6.1144. [DOI] [PubMed] [Google Scholar]
  • 15.Alderman M, Sealey J, Cohen H, et al. Urinary sodium excretion and myocardial infarction in hypertensive patients: A prospective cohort study. Am J Clin Nutr. 1997;65(suppl):682S–6S. doi: 10.1093/ajcn/65.2.682S. [DOI] [PubMed] [Google Scholar]
  • 16.Abbott D, Campbell N, Carruthers-Czyzewski P, et al. Directives pour la mesure et la surveillance de la tension artérielle ainsi que pour les interventions sur le mode de vie. Can J Public Health. 1994;85(suppl2):S36–S43. [Google Scholar]
  • 17.Evans CE. Canadian Hypertension Society. 1990. The Canadian Consensus on Hypertension Management. [Google Scholar]
  • 18.National Institutes of Health. HIH Publication. 1997. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. [Google Scholar]
  • 19.Sanchez-Castillo CP, Warrender S, Whitehead TP, James WPT. An assessment of the sources of dietary salt in a British population. Clinical Science. 1987;72:95–102. doi: 10.1042/cs0720095. [DOI] [PubMed] [Google Scholar]
  • 20.Godlee F. The food industry fights for salt. BMJ. 1996;312:1239–40. doi: 10.1136/bmj.312.7041.1239. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Joossens JV, Sasaki S, Kesteloot H. Bread as a source of salt: An international comparison. J Am Coll Nutr. 1994;13(2):179–83. doi: 10.1080/07315724.1994.10718392. [DOI] [PubMed] [Google Scholar]
  • 22.Law MR, Frost CD, Wald NJ. III-Analysis of data from trials of salt reduction. BMJ. 1991;302:819–24. doi: 10.1136/bmj.302.6780.819. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Dennis BH. Public health policy and salt: Doing the right thing. Perspectives in Applied Nutrition. 1995;3(2):121–23. [Google Scholar]
  • 24.Anonyme. Santé et Bien-être social Canada. 1992. Pour mieux se servir du Guide alimentaire. [Google Scholar]
  • 25.Couig MP. The new food label. AJN. 1993;2:68–72. [PubMed] [Google Scholar]
  • 26.Rheinstein PH. Update on food labeling. Am Fam Physician. 1993;47(4):979–82. [PubMed] [Google Scholar]
  • 27.Viscusi WK. Efficacy of labeling of foods and pharmaceuticals. Annu Rev Public Health. 1994;15:325–43. doi: 10.1146/annurev.pu.15.050194.001545. [DOI] [PubMed] [Google Scholar]
  • 28.Reid D, Hendricks SM. Consumer understanding and use of fat and cholesterol information on food labels. Rev can santé publique. 1994;85(5):334–37. [PubMed] [Google Scholar]
  • 29.Zarkin GA, Dean N, Mauskopf JA, Williams R. Potential health benefits of nutrition label changes. Am J Public Health. 1993;83:717–24. doi: 10.2105/AJPH.83.5.717. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Ministère de la Santé et des Services sociaux. Le Québec comparé: Indicateurs sanitaires, démographiques et socio-économiques. 1995. [Google Scholar]
  • 31.Karppanen H, Mervaala E. Adherence to and population impact of non-pharmacological and pharmacological antihypertensive therapy. J Hum Hypertens. 1996;10(Suppl.I):S57–S61. [PubMed] [Google Scholar]
  • 32.Kaplan NM. Salt and blood pressure, dans: Black HR, Hypertension Primer: The Essentials of High Blood Pressure. Dallas: American Heart Association; 1999. pp. 247–49. [Google Scholar]

Articles from Canadian Journal of Public Health = Revue Canadienne de Santé Publique are provided here courtesy of Springer

RESOURCES